
About Schatz Pharmaceauticals Private Limited
Data last updated:
Schatz Pharmaceauticals Private Limited is a private limited company based in Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 29 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2015PTC285741. Its GSTIN is 07AAWCS2308C1ZD (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Isharullah Siddiki and Kausar Jahan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 1 Kh No. 20/13/2 Amberhai Near Pole No. J894 Dwarka Sector – 19, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.3 Lakh, a growth of 48% compared to the previous year. For the same year it recorded a net loss of ₹1.38 Lakh (net margin -22%) and EBITDA of -₹1.38 Lakh (EBITDA margin -21.9%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website schatzpharma.com.
Company details
Contact details
Schatz Pharmaceauticals Private Limited's registered office is in Delhi, Delhi. Its website is schatzpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 1 Kh No. 20/13/2 Amberhai Near Pole No. J894 Dwarka Sector – 19, Delhi, India – 110075
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Schatz Pharmaceauticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Schatz Pharmaceauticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Schatz Pharmaceauticals Private Limited, buy the company report.
Financials of Schatz Pharmaceauticals Private Limited
FY 2025 filings availableSchatz Pharmaceauticals Private Limited reported revenue of ₹6.3 Lakh (up 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 48% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -21.9% | ||||
| Net Profit Margin | -22% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Schatz Pharmaceauticals Private Limited, buy the company report.
Board of directors of Schatz Pharmaceauticals Private Limited
Schatz Pharmaceauticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Isharullah Siddiki | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
| Kausar Jahan | Director | 31 Mar 2017 | 9 Years 7 Months | Current |
Peer comparison
Schatz Pharmaceauticals Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MH 26 Farmer Producer Company Limited | ₹6.3 Lakh (FY 2025) | 24.0% | Mukhed, Maharashtra, India | |||
| Electrex Power Tools Private Limited | ₹6.3 Lakh (FY 2021) | 12.0% | Mumbai, Maharashtra, India | |||
| Linking Export Private Limited | ₹6.3 Lakh (FY 2019) | Delhi, India | ||||
| Homospacian Ventures Private Limited | ₹6.3 Lakh (FY 2025) | 15.0% | Delhi, India | |||
| Hitech Fashion Wear Private Limited | ₹6.3 Lakh (FY 2024) | 2.0% | New Delhi, Delhi, India | |||
| Schatz Pharmaceauticals Private Limitedthis company | ₹6.3 Lakh (FY 2025) | -₹1.38 Lakh | -22% | 48.0% | Delhi, India | |
| Guru Ram Das Steels and Minerals Private Limited | ₹6.3 Lakh (FY 2025) | 3.0% | Kalunga, Odisha, India | |||
| Shivpujan Barter Pvt.Ltd. | ₹6.3 Lakh (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Raghav Fabrics Pvt Ltd | ₹6.3 Lakh (FY 2022) | 7.0% | Bhilwara, Rajasthan, India | |||
| Nidhi Ceramics Private Limited | ₹6.29 Lakh (FY 2016) | 0.0% | New Delhi, Delhi, India | |||
| Cefiro India Private Limited | ₹6.29 Lakh (FY 2025) | -89.0% | New Delhi, Delhi, India |
To see the full peer comparison of Schatz Pharmaceauticals Private Limited, buy the company report.
Shareholding
The shareholding of Schatz Pharmaceauticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Schatz Pharmaceauticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Schatz Pharmaceauticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Schatz Pharmaceauticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Schatz Pharmaceauticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAWCS2308C1ZD | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Schatz Pharmaceauticals Private Limited, buy the company report.
Recent activity
Schatz Pharmaceauticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Kausar Jahan was appointed as Director on 31 Mar 2017.
Frequently asked questions
Schatz Pharmaceauticals is an active private limited company based in Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 29 September 2015 (11+ years old) and is registered under CIN U51397DL2015PTC285741.
Schatz Pharmaceauticals has 2 current directors:
- Isharullah Siddiki - Director
- Kausar Jahan - Director
The latest financial statements of Schatz Pharmaceauticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Schatz Pharmaceauticals is 07AAWCS2308C1ZD, registered in Delhi.
The CIN (Corporate Identification Number) of Schatz Pharmaceauticals is U51397DL2015PTC285741. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Schatz Pharmaceauticals was incorporated on 29 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Schatz Pharmaceauticals by revenue are MH 26 Farmer Producer Company Limited, Electrex Power Tools Private Limited, Linking Export Private Limited, Homospacian Ventures Private Limited, Hitech Fashion Wear Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Kausar Jahan was appointed as Director on 31 Mar 2017. Sushil Kumar Singh ceased to be Director on 31 Mar 2017. Isharullah Siddiki was appointed as Director on 29 Sep 2015. Schatz Pharmaceauticals has 4 board changes on record in total.
Schatz Pharmaceauticals can be reached through the website schatzpharma.com. Its registered office is in Delhi, India.
The registered office of Schatz Pharmaceauticals is at Plot No. 1 Kh No. 20132 Amberhai Near Pole No. J894 Dwarka Sector – 19, Delhi, India – 110075.
Schatz Pharmaceauticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.

